Gary W. Pace - 03 Mar 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Reporting relationship: Director
Issuer ticker: PCRX
Reported as of: 03 Mar 2022
Net transaction value: +$75,670
SEC form: 4
Accepted by SEC: 07 Mar 2022, 19:07:39 UTC
Prior SEC filing: 01 Mar 2022
Next SEC filing: 11 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Kristen Williams, Attorney-in-Fact

Key filing fact

Gary W. Pace filed Form 4 for Pacira BioSciences, Inc. (PCRX) on 07 Mar 2022.

Key facts

This page summarizes Gary W. Pace's Form 4 filing for Pacira BioSciences, Inc. (PCRX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Mar 2022, 19:07.

Change

Previous filing in this sequence was filed on 01 Mar 2022.
Current net transaction value: +$75,670.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCRX transaction

Common Stock

Options Exercise

Transaction value: $75,670
Shares: +7,000
Change %: +5.4%
Price: $10.81
Shares after: 136,530
Date: 03 Mar 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCRX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -7,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,000
Exercise price: $10.81
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 5, 2012.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .